Article metrics

Download PDFPDF

Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1α and anti-interleukin-1β dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis

 

Online download statistics by month:

Online download statistics by month: December 2018 to September 2020

AbstractFullPdf
Dec 2018930956149
Jan 201947552376
Feb 2019521509101
Mar 201926025885
Apr 201914313439
May 201912411776
Jun 201911411055
Jul 201910610153
Aug 2019636121
Sep 2019616017
Oct 2019757114
Nov 2019706524
Dec 2019838037
Jan 2020847938
Feb 2020817626
Mar 2020767322
Apr 2020676655
May 2020837476
Jun 2020656421
Jul 2020585322
Aug 2020565325
Sep 202049409
Total364436231041